|
Real-time Estimate
Cboe BZX
14:57:33 21/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 6.705 USD | +0.37% |
|
+1.36% | -37.04% |
| 09-28 | CapsoVision, Inc. Announces Fda Clearance of Ai Highlights for Capsocam Plus | CI |
| 09-28 | CapsoVision Gets FDA Clearance for AI-Assisted Capsule Endoscopy Tool | MT |
| Market Cap | 334M 298M 276M 250M 470M 31.67B 478M 3.31B 1.3B 16.57B 1.25B 1.23B 52.87B | P/E 2026 * |
-11.9x | P/E 2027 * | -15.2x |
|---|---|---|---|---|---|
| Enterprise Value | 334M 298M 276M 250M 470M 31.67B 478M 3.31B 1.3B 16.57B 1.25B 1.23B 52.87B | EV / Sales 2026 * |
22.5x | EV / Sales 2027 * | 16.9x |
| Free-Float |
69.86% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CV | Delayed | |
CBOE
| CV | Real-time | |
|
Deutsche Boerse AG
| H6U | Delayed |
Last Transcript: CapsoVision, Inc.
| 1 day | +0.45% | ||
| 1 week | +1.36% | ||
| Current month | +4.18% | ||
| 1 month | +8.72% | ||
| 3 months | -4.13% | ||
| 6 months | +13.11% | ||
| Current year | -37.04% |
| 1 week | 6.24 |  | 6.78 |
| 1 month | 5.88 | | 6.98 |
| Current year | 4.5 | | 11.37 |
| 1 year | 4.5 | | 15.37 |
| 3 years | 3.43 | | 15.37 |
| 5 years | 3.43 | | 15.37 |
| 10 years | 3.43 | | 15.37 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kang-Huai Wang
CEO | Chief Executive Officer | 69 | 31/10/2024 |
David Garcia
DFI | Director of Finance/CFO | 52 | - |
Keri Jorgenson
PRN | Corporate Officer/Principal | - | 28/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Kang-Huai Wang
BRD | Director/Board Member | 69 | 31/10/2024 |
Chen Lung Tsai
CHM | Chairman | 74 | 31/12/2024 |
Hui Ying Kuo
BRD | Director/Board Member | 55 | 31/01/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/09/26 | Buy | Director | 1,757,469 | 3.5263% | ||
| 15/09/26 | Buy | 878,734 | 1.7632% | |||
| 15/09/26 | Buy | 878,734 | 1.7632% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.37% | +1.36% | +39.92% | - | 334M | |
| +0.75% | +2.55% | +23.72% | +49.49% | 254B | |
| +2.86% | +2.16% | +3.98% | +12.50% | 158B | |
| -3.54% | +1.71% | -7.63% | +56.81% | 155B | |
| -0.88% | +5.87% | -54.43% | -9.19% | 66.06B | |
| +0.04% | +8.20% | +11.00% | +64.88% | 51.6B | |
| +0.77% | +4.52% | -13.83% | -10.84% | 51.82B | |
| -0.20% | +3.11% | +17.26% | +29.09% | 50.89B | |
| +1.96% | +1.50% | +21.23% | +61.52% | 48.78B | |
| +2.36% | +3.39% | +29.25% | +76.56% | 43.51B | |
| Average | +0.50% | +2.88% | +7.05% | +36.76% | 87.95B | |
| Weighted average by Cap. | +0.34% | +3.20% | +5.61% | +37.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.87M 13.24M 12.27M 11.12M 20.89M 1.41B 21.24M 147M 57.83M 737M 55.79M 54.63M 2.35B | 19.82M 17.64M 16.35M 14.82M 27.85M 1.88B 28.31M 196M 77.08M 983M 74.35M 72.81M 3.13B |
| Net income | -27.56M -24.53M -22.73M -20.6M -38.71M -2.61B -39.36M -273M -107M -1.37B -103M -101M -4.36B | -22.1M -19.67M -18.23M -16.52M -31.05M -2.09B -31.57M -219M -85.94M -1.1B -82.9M -81.18M -3.5B |
| Net Debt | - | - |
Employees
99
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/10/26 | US$6.730 | +0.75% | 941 |
| 20/10/26 | US$6.680 | +0.15% | 62,352 |
| 19/10/26 | US$6.670 | +2.14% | 76,162 |
| 16/10/26 | US$6.530 | +1.24% | 160,778 |
| 15/10/26 | US$6.450 | -2.86% | 169,971 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.680USD
Average target price
9.500USD
Spread / Average Target
+42.22%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CV Stock
Select your edition
All financial news and data tailored to specific country editions
